Who Generates Higher Gross Profit? Amgen Inc. or Grifols, S.A.

Amgen Inc. vs. Grifols, S.A.: A Decade of Gross Profit Comparison

In the competitive landscape of the pharmaceutical industry, Amgen Inc. and Grifols, S.A. have been key players. Over the past decade, from 2014 to 2023, Amgen consistently outperformed Grifols in terms of gross profit. Amgen's gross profit grew by approximately 27% over this period, peaking in 2022 with a remarkable $19.9 billion. In contrast, Grifols saw a more modest increase of around 37%, reaching its highest gross profit of $2.34 billion in 2019.

Despite Grifols' impressive growth rate, Amgen's gross profit remains nearly ten times higher, underscoring its dominant market position. This data highlights the significant scale and efficiency of Amgen's operations compared to Grifols. As the pharmaceutical industry continues to evolve, these insights provide a valuable perspective on the financial health and strategic positioning of these two giants.